Telehealth has become a real, often more accessible way to start and continue buprenorphine treatment — particularly valuable for people without easy access to an in-person addiction medicine specialist.
What changed to make this possible: Pandemic-era flexibilities allowed buprenorphine to be prescribed via telehealth without a prior in-person visit, and many of these flexibilities have been extended — check current rules, since telehealth prescribing policy for controlled substances has continued to evolve.
What a telehealth visit typically involves: A video (or sometimes phone) consultation covering your use history, health background, and treatment goals, followed by a prescription sent to your local pharmacy if buprenorphine is appropriate for you.
What telehealth can’t do: Some formulations (Sublocade, Brixadi injections) require an in-person visit for administration — telehealth generally applies to prescribing the sublingual (daily) forms.
What to look for in a telehealth provider: Confirm they’re licensed in your state specifically (telehealth prescribers must generally be licensed where the patient is located, not just where the provider is based), and ask about their process for urgent questions between visits.
A reasonable starting point: Search for telehealth OUD treatment providers alongside checking SAMHSA’s provider locator, since not all telehealth options are listed in the same directories as in-person clinics.
Medically reviewed by [pending]. Sources: SAMHSA telehealth guidance, DEA telehealth prescribing rules for controlled substances.